Kelly Esperias Appointed Chief Strategy Officer at NORD
![Kelly Esperias Appointed Chief Strategy Officer at NORD](/images/blog/ihnews-Kelly%20Esperias%20Appointed%20Chief%20Strategy%20Officer%20at%20NORD.jpg)
Kelly Esperias Takes the Helm at NORD as Chief Strategy Officer
The National Organization for Rare Disorders (NORD) has recently appointed Kelly Esperias, EdD, MBA, CFRE, as its Chief Strategy & Operations Officer, marking a significant step forward for the organization. Esperias brings an extensive background in operations, financial management, and strategic leadership to her new role, positioning her to shape NORD's future.
Bringing a Wealth of Experience to NORD
Before joining NORD, Esperias served as the Chief Financial & Operating Officer at Keck Graduate Institute, where she demonstrated remarkable skills in managing operations across various sectors. Her experience spans corporate partnerships, finance, and marketing, making her well-suited to lead NORD's strategic initiatives.
"NORD has been a source of hope for the rare disease community for over four decades, and I am honored to contribute to this vital mission," commented Esperias. Her commitment to improving lives through innovation is evident, as she aims to enhance access to care and support for families affected by rare diseases.
NORD: A Leader in Rare Disease Advocacy
Founded in 1983, NORD stands as the nation's premier nonprofit organization dedicated to the rare disease community. With a network of over 350 patient advocacy organizations, NORD plays a crucial role in advocating for patients and their families, ensuring they receive necessary resources and support.
"Kelly's extensive leadership experience in operations within the biotechnology sector will play a pivotal role in steering NORD's growth and innovation in the coming years," noted Pamela Gavin, NORD's Chief Executive Officer. Her insights and strategic approach are expected to yield significant progress in enhancing services for those impacted by rare diseases.
Esperias' Career Journey and Accomplishments
Esperias' career began at Anschutz Entertainment Group (AEG), where she managed merchandising operations for Major League Baseball's Los Angeles Angels. This role required her to oversee a large team, laying the groundwork for her exceptional skills in operational management and leadership.
At Servite Catholic High School as Director of Marketing and Communications, Esperias successfully implemented strategies to boost student enrollment and secure funding for a capital campaign, showcasing her ability to drive results and advance institutional goals.
Joining Keck Graduate Institute in 2011 as Vice President of Institutional Development & Partnerships, she transformed fundraising and corporate partnership strategies, continuously exceeding expectations. Her analytical skills led her to the Chief Financial and Operating Officer position, where she oversaw critical departments and initiatives.
A Commitment to the Rare Disease Community
Over nearly a decade at KGI, Esperias contributed significantly to the development of innovative academic programs in biotechnology. Her work has directly influenced the growth of health sciences, highlighting her deep understanding of challenges faced by the rare disease community.
Esperias holds a doctorate in Organizational Change and Leadership from the University of Southern California and boasts an impressive educational background, including an MBA and a bachelor's degree from prestigious institutions. Furthermore, she possesses certification as a fundraising executive, augmenting her proficiency in nonprofit management.
Under her leadership, NORD anticipates advancements in its strategic plan and expansion in advocacy efforts for rare diseases. Esperias is eager to collaborate with NORD's remarkable team to refine the organization's mission and enhance the support provided to families in need.
Frequently Asked Questions
Who is Kelly Esperias?
Kelly Esperias is the newly appointed Chief Strategy & Operations Officer at NORD, bringing extensive experience in operations and strategic leadership.
What are Kelly Esperias's responsibilities at NORD?
She will shape and execute NORD's strategic plan while overseeing finances, human resources, and various operational functions.
What is NORD's mission?
NORD aims to improve the lives of individuals and families affected by rare diseases by providing advocacy, resources, and support.
How does NORD support the rare disease community?
NORD connects patients with advocacy organizations and works on policy initiatives to enhance care and treatment options for rare diseases.
What qualifications does Kelly Esperias have?
She holds a doctorate in Organizational Change and Leadership, an MBA, and is a Certified Fundraising Executive with extensive experience in healthcare and biotechnology.
About The Author
Contact Addison Perry privately here. Or send an email with ATTN: Addison Perry as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.